Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A2 (sPLA2) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A2 (sPLA2) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 24, Pages 9396
Publisher
MDPI AG
Online
2020-12-10
DOI
10.3390/ijms21249396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients
- (2020) Sofie S. Jespersen et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling
- (2020) Arti Verma et al. BIOCHEMICAL PHARMACOLOGY
- Sterically stabilized liposomes targeting P21 (RAC1) activated kinase‑1 and secreted phospholipase A2 suppress prostate cancer growth and metastasis
- (2020) Arti Verma et al. Oncology Letters
- p21 Activated kinase 1: Nuclear activity and its role during DNA damage repair
- (2018) Eloy Andrés Pérez-Yépez et al. DNA REPAIR
- P21 activated kinase signaling in cancer
- (2018) Chetan K. Rane et al. SEMINARS IN CANCER BIOLOGY
- Liposome-targeted delivery for highly potent drugs
- (2017) Hassan Bardania et al. Artificial Cells Nanomedicine and Biotechnology
- Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study
- (2016) Thomas P. Ahern et al. ACTA ONCOLOGICA
- Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo
- (2016) Ahmad Al-Azayzih et al. Nanomedicine-Nanotechnology Biology and Medicine
- Liposomal Drug Delivery: A Versatile Platform for Challenging Clinical Applications
- (2016) Asadullah Madni et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition
- (2015) Ahmad Al-Azayzih et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- New approaches for improving outcomes in breast cancer in Europe
- (2015) Angelo Di Leo et al. BREAST
- Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells
- (2015) T Y Prudnikova et al. ONCOGENE
- Secreted phospholipases A2 are differentially expressed and epigenetically silenced in human breast cancer cells
- (2014) Vesna Brglez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibitors of p21-Activated Kinases (PAKs)
- (2014) Joachim Rudolph et al. JOURNAL OF MEDICINAL CHEMISTRY
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2responsive liposome in prostate cancer
- (2012) J. N. Mock et al. Integrative Biology
- P21 Activated Kinase-1 (Pak1) Promotes Prostate Tumor Growth and Microinvasion via Inhibition of Transforming Growth Factor β Expression and Enhanced Matrix Metalloproteinase 9 Secretion
- (2012) Anna Goc et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Essential Role of Cdc42 in Ras-Induced Transformation Revealed by Gene Targeting
- (2012) Kristy R. Stengel et al. PLoS One
- Secretory phospholipase A 2 responsive liposomes
- (2011) Guodong Zhu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
- (2011) Y Shrestha et al. ONCOGENE
- Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
- (2011) C. C. Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PAK1 as a therapeutic target
- (2010) Julia V Kichina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Signalling to cancer cell invasion through PAK family kinases
- (2010) Andrew Whale Frontiers in Bioscience-Landmark
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pak protein kinases and their role in cancer
- (2009) Bettina Dummler et al. CANCER AND METASTASIS REVIEWS
- An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently
- (2009) J. Viaud et al. MOLECULAR CANCER THERAPEUTICS
- An Isoform-Selective, Small-Molecule Inhibitor Targets the Autoregulatory Mechanism of p21-Activated Kinase
- (2008) Sean W. Deacon et al. CHEMISTRY & BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started